4568 Stock Overview
Manufactures, markets, and sells pharmaceutical products worldwide.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 4/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for 4568 from our risk checks.
Daiichi Sankyo Company, Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥5,422.00 |
52 Week High | JP¥5,848.00 |
52 Week Low | JP¥3,566.00 |
Beta | 0.25 |
1 Month Change | -1.09% |
3 Month Change | 12.58% |
1 Year Change | 12.12% |
3 Year Change | 115.97% |
5 Year Change | 180.98% |
Change since IPO | 602.64% |
Recent News & Updates
Here's Why Daiichi Sankyo Company (TSE:4568) Has Caught The Eye Of Investors
May 22Statutory Profit Doesn't Reflect How Good Daiichi Sankyo Company's (TSE:4568) Earnings Are
May 02Recent updates
Here's Why Daiichi Sankyo Company (TSE:4568) Has Caught The Eye Of Investors
May 22Statutory Profit Doesn't Reflect How Good Daiichi Sankyo Company's (TSE:4568) Earnings Are
May 02Daiichi Sankyo Company, Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Apr 27Daiichi Sankyo Company (TSE:4568) Is Paying Out A Larger Dividend Than Last Year
Mar 11Daiichi Sankyo Company (TSE:4568) Will Pay A Larger Dividend Than Last Year At ¥30.00
Feb 26Shareholder Returns
4568 | JP Pharmaceuticals | JP Market | |
---|---|---|---|
7D | -7.0% | -2.5% | -0.2% |
1Y | 12.1% | -2.1% | 16.8% |
Return vs Industry: 4568 exceeded the JP Pharmaceuticals industry which returned -2.1% over the past year.
Return vs Market: 4568 underperformed the JP Market which returned 16.8% over the past year.
Price Volatility
4568 volatility | |
---|---|
4568 Average Weekly Movement | 4.7% |
Pharmaceuticals Industry Average Movement | 3.8% |
Market Average Movement | 4.0% |
10% most volatile stocks in JP Market | 7.5% |
10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 4568 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4568's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1899 | 17,435 | Sunao Manabe | www.daiichisankyo.com |
Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia. It also provides olmesartan medoxomil antihypertensive agents; NILEMDO, an oral treatment to help in lowering cholesterol; and Nustendi, a fixed-dose combination tablet of bempedoic acid and ezetimibe for reducing cholesterol.
Daiichi Sankyo Company, Limited Fundamentals Summary
4568 fundamental statistics | |
---|---|
Market cap | JP¥10.36t |
Earnings (TTM) | JP¥200.73b |
Revenue (TTM) | JP¥1.60t |
51.6x
P/E Ratio6.5x
P/S RatioIs 4568 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
4568 income statement (TTM) | |
---|---|
Revenue | JP¥1.60t |
Cost of Revenue | JP¥415.32b |
Gross Profit | JP¥1.19t |
Other Expenses | JP¥985.64b |
Earnings | JP¥200.73b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 105.01 |
Gross Margin | 74.07% |
Net Profit Margin | 12.53% |
Debt/Equity Ratio | 6.0% |
How did 4568 perform over the long term?
See historical performance and comparison